Nutritional knowledge for patients taking anti-obesity medications
Newswise — By Jaime Almandoz, MD, Associate Professor Internal medicine in the Endocrinology department Since obesity drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have become more widely known and prescribed, they have been touted as breakthrough treatments for chronic overweight and obesity. Anti-obesity drugs work by signaling to the brain that we … Read more